Conclusion This multiplex immunofluorescence assay provides an approach to accurately and precisely measure HER2/TROP2 levels within breast cancer tissue and compare relative levels of target ...

Hepion is a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), helicobacter ...

The development of an epigenetic, multiplex PCR test may be an effective tool in detecting prostate cancer.

Methods: A rapid, straightforward, sensitive, high-throughput, and precise multiplex PCR-dipstick DNA chromatography assay was devised. This innovative technique was specifically engineered for the ...

--Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis, hepatocellular carcinoma, and other chronic liver ...

The Respiratory Panel RT-PCR Multiplex CE-IVD addresses a $5.6 billion market, growing at 6.6% annually through 2029, by enabling efficient, simultaneous detection of COVID-19, Influenza A/B, and ...

The Respiratory Panel RT-PCR Multiplex CE-IVD addresses a $5.6 billion market, growing at 6.6% annually through 2029, by enabling efficient, simultaneous detection of COVID-19, Influenza A/B, and ...

Since then, researchers have developed over-the-counter multiplex tests that can screen for more than one respiratory infection at once.